← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2014Last known activity
Jan 28, 2021
Timeline
1990s
- Jun 1, 1998
BioClinica, Inc.— Founded
2000s
- Sep 2, 2009
CardioNow— Acquired
- Sep 16, 2009
Tourtellotte Solutions— Acquired
2010s
- Mar 26, 2010
TranSenda International— Acquired
- Jan 16, 2014
CCBR Clinical Research— Acquired
- Mar 12, 2014
Synarc— Acquired
- Jun 16, 2014
Blueprint Clinical— Acquired
- Sep 21, 2015
Synowledge— Acquired
- Jan 20, 2016
Clinverse— Acquired
- Jul 25, 2016
Compass Research— Acquired
- Nov 7, 2017
MDDX Research & Informatics— Acquired
Drugs by trial phase (21 distinct, 20 trials)
Phase 3 (1 own, 3 via acquisition)
Phase 2 (1 own, 5 via acquisition)
Phase 1 (5 own, 6 via acquisition)
Indications
Studied for
- Aphasia, Primary Progressive
- Cardiotoxicity
- Communicable Diseases
- Condylomata Acuminata
- Dementia
- DNA Virus Infections
- Frontotemporal Dementia
- Infections
- Long QT Syndrome
- Nasal Polyps
- Papillomavirus Infections
- Pick Disease of the Brain
- Polyps
- Sexually Transmitted Diseases
- Sexually Transmitted Diseases, Viral
- Skin Diseases
- Skin Diseases, Infectious
- Skin Diseases, Viral
- Tumor Virus Infections
- Virus Diseases
- Warts
Subsidiaries (10 direct, 10 total across the full acquisition tree)
Recent trials (7)
- NCT04607005CollaboratorPhase 3Jan 28, 2021
- NCT04111666Overall official - principal investigatorPhase 1Dec 14, 2019
- NCT05713773CollaboratorPhase 1Oct 25, 2019
- NCT03981822CollaboratorPhase 2Jun 27, 2019
- NCT03636204Overall official - principal investigatorPhase 1Sep 14, 2018
- NCT03487549CollaboratorPhase 2Mar 27, 2018
- NCT02119091CollaboratorPhase 1Apr 1, 2014
Details
- Founded
- Newtown, PA, US Jun 1, 1998
- Last known activity
- Jan 28, 2021